SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs >

Alexza Pharmaceuticals Inc. (ALXA)

ALXA RSS Feed
Add ALXA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 5/17/2016 5:51:37 PM - Followers: 80 - Board type: Free - Posts Today: 0

 

Alexza Pharmaceuticals Inc.


Revolutionary Technology

Revolutionary Technology


Alexza Pharmaceuticals is a rapidly emerging pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS conditions. All of our product candidates are based on our proprietary technology, the Staccato® system. The Staccato system vaporizes excipient-free drugs to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the ideal particle size of the aerosol, the pure drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous (IV) administration but with greater ease, patient comfort and convenience.

Alexza's lead program is ADASUVE (Staccato loxapine or AZ-004), being developed for the acute treatment of agitation in patients with schizophrenia or bipolar disease. During 2011, Alexza resubmitted the ADASUVE NDA and the ADASUVE MAA in Europe.  Alexza has a U.S. PDUFA goal date for ADASUVE of February 4, 2012.






 

 

Staccato nicotine (Preclinical)

http://www.alexza.com/
http://finance.yahoo.com/q/ks?s=ALXA

Alexza Pharmaceuticals, Inc., a development stage company, focuses on the development and commercialization of products for the treatment of acute and intermittent conditions primarily in the United States. Its technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The company has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Its product candidate AZ-001 completed Phase IIb Clinical Trial; AZ-004 completed Phase IIa Clinical Trial; AZ-002 is in Phase IIa Clinical Trials; and AZ-003 completed a Phase I Clinical Trial. Alexza Pharmaceuticals has a development agreement with Autoliv ASP, Inc. for the development of heat packages that can be incorporated into proprietary single dose drug delivery device. The company, formerly known as FaxMed, Inc., was founded in 2000. FaxMed changed its name to Alexza Corporation in June 2001 and to Alexza Molecular Delivery Corporation in December 2001. Further, it changed its name to Alexza Pharmaceuticals, Inc. in July 2005. The company is based in Palo Alto, California.

Biography Photo Thomas B. King
President, Chief Executive Officer

Thomas B. King has served as our President, Chief Executive Officer and a member of our Board since June 2003. From September 2002 to April 2003, Mr. King served as President, Chief Executive Officer and a member of the board of directors of Cognetix, Inc., a biopharmaceutical development company. From January 1994 to February 2001, Mr. King held various senior executive positions, including President and Chief Executive Officer from January 1997 to October 2000, and was a member of the board of directors at Anesta Corporation, a publicly traded pharmaceutical company, until it was acquired by Cephalon, Inc., a publicly traded biopharmaceutical company. Mr. King received an M.B.A. from the University of Kansas and a B.A. in chemistry from McPherson College.



[

 


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALXA
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ALXA News: Statement of Ownership: Solicitation (sc 14d9) 05/23/2016 09:32:54 AM
ALXA News: INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza Pharmaceuticals, Inc. & Encourages S... 05/16/2016 10:10:00 PM
ALXA News: ALEXZA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Believe the Acquisitio... 05/16/2016 01:01:00 PM
ALXA News: SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza Pharmaceuticals, Inc. & Encourage... 05/13/2016 11:15:00 PM
ALXA News: Quarterly Report (10-q) 05/13/2016 04:04:25 PM
PostSubject
#3193   .0001 CarlCarlMcB 05/17/16 05:51:37 PM
#3192   The initial, unbinding letter of intent filed (I dangerbowman 05/10/16 03:18:30 PM
#3191   So do I sell today or hold on damondon 05/10/16 02:41:03 PM
#3190   so what happens after this? The Devils Reject 05/10/16 01:29:18 PM
#3189   New 8K MERGER APPROVED! Ferrer will buy up JAVA_1 05/10/16 07:43:05 AM
#3188   back to 0.50 post market lngnstrng 03/28/16 04:33:10 PM
#3187   news is out. disappointing. enough with the pumping. lngnstrng 03/28/16 04:20:43 PM
#3186   With good news we could see $1 go Alxa CashMoneyNY 03/28/16 02:12:39 PM
#3185   Holding at .72 now its time for the push CashMoneyNY 03/28/16 01:56:16 PM
#3184   Alexza Pharmaceuticals Incorporated to release 2015 earnings today. CashMoneyNY 03/28/16 11:31:26 AM
#3183   Investor Conference Call: Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) Posted by: CashMoneyNY 03/28/16 10:44:17 AM
#3182   Support building up again that's great could close CashMoneyNY 03/28/16 10:18:49 AM
#3181   No bad lets shake out the flippers CashMoneyNY 03/28/16 10:03:05 AM
#3180   Let it fly people we have news coming today CashMoneyNY 03/28/16 09:37:56 AM
#3179   Nice volume at the start CashMoneyNY 03/28/16 09:35:52 AM
#3178   i think we can expect some news on lngnstrng 03/25/16 07:38:50 PM
#3177   Nice call ! CarlCarlMcB 03/25/16 07:10:36 PM
#3176   wtf happened? nice candle this afternoon lngnstrng 03/24/16 04:21:18 PM
#3175   Oh no Timber! CarlCarlMcB 03/14/16 10:51:04 AM
#3174   no specific prize yet but a LOI to lngnstrng 03/11/16 05:31:24 PM
#3173   Is there a buyout offer? damondon 03/11/16 01:29:05 PM
#3172   $1? $2? $3? $4? $5? lngnstrng 03/11/16 03:05:25 AM
#3171   what buyout prize will shareholders accept? opinions? lngnstrng 03/10/16 12:25:56 PM
#3170   Lol CarlCarlMcB 03/09/16 07:26:57 PM
#3169   * * $ALXA Video Chart 02-29-16 * * ClayTrader 02/29/16 04:51:19 PM
#3168   How do you like that carl? Updated 02/29/16 04:26:41 PM
#3167   ALXA .60 LOOKING for .70s++ tomorrow PAC 02/29/16 03:54:52 PM
#3166   Huge move up!!! Maybe a sign of The_One13 02/29/16 02:40:13 PM
#3165   Any ideas to where this is heading? Penny_God 02/29/16 12:21:15 PM
#3164   Bought at .6008.... stupid to do DMRX 02/29/16 11:00:32 AM
#3163   $$$$$$$$$$$$ Tdash 02/29/16 10:24:31 AM
#3162   Very nice! cjstocksup 02/29/16 10:22:21 AM
#3161   NICE!!! Tdash 02/29/16 10:02:04 AM
#3160   Looking for pull back ! CarlCarlMcB 02/29/16 09:52:10 AM
#3159   Timber CarlCarlMcB 02/04/16 11:22:07 AM
#3158   .00001 CarlCarlMcB 01/16/16 10:33:13 AM
#3157   Coooooovvvver your shorts u are in trouble now marina22 01/16/16 08:42:09 AM
#3156   Will see .01 now CarlCarlMcB 01/16/16 08:37:46 AM
#3155   Even more WRONG marina22 01/16/16 08:37:01 AM
#3154   Wrong marina22 01/16/16 08:34:51 AM
#3153   .10 CarlCarlMcB 01/07/16 03:57:43 PM
#3152   Sadness. Not much to take this down over presence 01/06/16 10:54:40 AM
#3151   .25 CarlCarlMcB 12/28/15 11:12:02 AM
#3150   Very small float, we should see at least T695 12/22/15 09:57:44 AM
#3149   Wish I was able to short from T695 12/22/15 09:54:33 AM
#3148   Long T695 12/22/15 09:49:42 AM
#3147   long or short? [SMART MONEY] 12/22/15 09:47:27 AM
#3146   In at .92 T695 12/22/15 09:41:36 AM
#3145   Starting to look like a great short, no T695 12/22/15 08:03:41 AM
#3144   OK SO MAYBE I SHOULD SHORT THIS bonappetite85 12/22/15 07:59:33 AM
PostSubject